The neurotoxicant lead (Pb2+) has been studied extensively regarding neurodevelopmental impacts altering the glutamatergic system that persists across the life span. Recently, research has been redirected toward revisiting Pb2+-impacts on the neurodevelopment of the GABAergic system because it precedes the functional expression and activation of the glutamatergic system. Because the potassium chloride cotransporter (KCC2) drives the developmental regulatory shift from GABA-excitation-to-inhibition, and that the GABAA receptors activation can alter gene expression via excitation-dependent coupling of voltage sensitive calcium channels (VSCC), it is important to investigate how Pb2+-exposure might also alter the development, function, and activation of the GABAergic system. Here the relationship between control and 1,000 ppm perinatal Pb2+-exposed rats (i.e., from gestation to postnatal day [PND-22]) on the KCC2 spatiotemporal expression in the ventro-medial prefrontal cortex (vmPFC) and hippocampus (i.e., DG and CA-3) at PND 2, 7, 14, and 22 was examined. Additionally, the KCC2, the VSCC-β3 subunit of the L-type calcium channel and the GABA-AR-β3 subunit expression were examined in primary neuronal cerebellar granule cell cultures (CGC) 3-DIV to assess the impacts of Pb2+-exposure on the VSCC-β3 excitation-dependent coupling in altering the GABA-shift. The results showed that developmental Pb2+-exposure elevated the KCC2 expression in vmPFC at PND 2 and reduced at PND 14 and 22; whereas in the DG, the KCC2 expression was elevated at PND 2 and 7, and reduced at PND 14. In the CA-3, the KCC2 expression was elevated at PND 2 and 7. In the PNC, Pb2+ did not affect cell viability or confluence, but it reduced the expression of KCC2 irrespective of Pb2+-dosage and dose-dependently for VSCC-β3. Notably, in the CGCs the GABA-AR-β3 expression showed a curvilinear relationship with the most impacts at low- (0.05–0.1 μmol/L) and high-Pb2+ doses (1.5 μmol/L) in-vitro. The data suggest that lower levels of Pb2+-exposure, at the cellular level, reduced VSCC-β3 and KCC2 expression, thereby delaying the GABA-shift. As a result, the altered GABA-AR-β3 expression, dependent upon its ability to compensate during development, can cause differential patterns of mature KCC2 expression across brain regions at PND 22. Thus, developmental Pb2+-exposure can alter the development of the GABAergic system prior to the functional expression and activation of the glutamatergic system.